Department of Surgery, Division of Pediatric Urology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
J Urol. 2020 Jun;203(6):1156-1162. doi: 10.1097/JU.0000000000000712. Epub 2020 Mar 24.
Shock wave lithotripsy and ureteroscopy are the most commonly performed surgeries for kidney and ureteral stones, but the comparative effectiveness of these interventions at the population level is unclear. We compared re-treatment for shock wave lithotripsy and ureteroscopy.
A retrospective cohort study using all-payer claims data for all patients who underwent shock wave lithotripsy or ureteroscopy from 1997 to 2016 at 74 hospitals in South Carolina was performed. The primary outcome measure was subsequent shock wave lithotripsy or ureteroscopy within 6 months of initial surgery. Pseudorandomized trials of ureteroscopy vs shock wave lithotripsy were performed for each year, applying propensity scores to balance hospital and patient characteristics. Discrete time failure models were fit using propensity score weighted logistic regression.
Overall 136,152 ureteroscopy and shock wave lithotripsy surgeries were performed in 95,227 unique patients with re-treatment representing 9% of all surgeries. A total of 74,251 index surgeries were shock wave lithotripsy (59.9%) and 49,743 were ureteroscopy (40.1%). Shock wave lithotripsy was associated with a 20% increased odds of re-treatment (OR 1.20; 95% CI 1.13-1.26). The probability of re-treatment was 7.5% for ureteroscopy and 10.4% for shock wave lithotripsy. Shock wave lithotripsy had the greatest risk of re-treatment at months 2 (OR 1.85; 95% CI 1.64-2.10) and 3 (OR 1.76; 95% CI 1.50-2.06). Patients with initial shock wave lithotripsy were more likely to have shock wave lithotripsy for re-treatment (84.6%) than those patients who had initial ureteroscopy were to have ureteroscopy (29.3%).
Compared to ureteroscopy, shock wave lithotripsy was associated with increased odds of re-treatment. These results have implications for shared decision making and value based surgical treatment of nephrolithiasis.
冲击波碎石术和输尿管镜检查是治疗肾结石和输尿管结石最常用的手术,但这些干预措施在人群水平上的相对有效性尚不清楚。我们比较了冲击波碎石术和输尿管镜检查的再治疗情况。
使用来自南卡罗来纳州 74 家医院 1997 年至 2016 年期间所有接受冲击波碎石术或输尿管镜检查的患者的所有支付者索赔数据进行回顾性队列研究。主要结局指标是初始手术后 6 个月内再次进行冲击波碎石术或输尿管镜检查。对输尿管镜检查与冲击波碎石术的每项年度伪随机试验进行了研究,应用倾向评分平衡医院和患者特征。使用倾向评分加权逻辑回归拟合离散时间失效模型。
共有 95227 名患者接受了 136152 次输尿管镜检查和冲击波碎石术,再治疗占所有手术的 9%。共有 74251 次指数手术为冲击波碎石术(59.9%),49743 次为输尿管镜检查(40.1%)。冲击波碎石术与再治疗的几率增加 20%相关(OR 1.20;95%CI 1.13-1.26)。输尿管镜检查的再治疗概率为 7.5%,冲击波碎石术为 10.4%。冲击波碎石术在第 2 个月(OR 1.85;95%CI 1.64-2.10)和第 3 个月(OR 1.76;95%CI 1.50-2.06)的再治疗风险最大。初始接受冲击波碎石术的患者更有可能接受冲击波碎石术进行再治疗(84.6%),而初始接受输尿管镜检查的患者更有可能接受输尿管镜检查进行再治疗(29.3%)。
与输尿管镜检查相比,冲击波碎石术与再治疗的几率增加相关。这些结果对肾结石的共同决策和基于价值的手术治疗具有影响。